Skip to content

CorQuest MedTech

Active
Private limited companyfounded 2019active for 7 yearsRue Lieut.Col.Maniette(TX) 4, 5020 Namur, BelgiumKBO/BCE: BE 0733.537.853
Summary

CorQuest MedTech has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €552,771 and a net result of -€194,609. Equity is growing by about 29% per year across the filed financial years. Its solvency ranks better than 82% of 146 sector peers (NACE 26, financial year 2025). The computed 12-month bankruptcy probability is 1.1% (low).

Risk analysisFollow ReportCompare
CorQuest MedTechActiveChecked score 66/100
Risk analysis ReportCompare

History

On 30 August 2019, CorQuest MedTech was incorporated as a private limited company.1 The registered office moved to Louvain-la-Neuve in 2024 and to Temploux in 2026.23 In 2024 the capital was increased by €435,000.4 Total assets went from €12,645 in 2020 to €675,137 in 2025 and headcount from 0.3 full-time equivalents in 2022 to 1 in 2025.5

  1. 1KBO register
  2. 2Belgian Official Gazette, 07-02-2024
  3. 3Belgian Official Gazette, 09-03-2026
  4. 4Belgian Official Gazette, 20-03-2024
  5. 5National Bank, annual accounts 2020, 2022 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
24-08
NBB filing Annual accounts filed
financial year 2025 · abbreviated format · 24 days late
09-03
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 20-02-2026
  • Registered-office move, Rue Lieutenant-Colonel Maniette 4 5020 Temploux
2025
31-12
Financial Weakest financial yearnet -€194,609
Net result drops to -€194,609, the lowest in the series.
31-08
NBB filing Annual accounts filed
financial year 2024 · full format · 31 days late
2024
31-12
Financial Equity above €500,000equity €747,380 ▲57.5%
Equity rises from €474,618 to €747,380.
01-10
Gazette deed Appointments: Séverine de Sadeleer (director) and Sandra Spiritelli (director)
Kind of shares · Financial instrument · Board rule14 facts ▸
  • General meeting, 11-07-2024
  • Other provision, “dispense de lecture des rapports, unanimité” (deed in French)
  • Kind of shares, “C, création” (deed in French)
  • Other provision, “dispense de lecture des documents, unanimité” (deed in French)
  • Financial instrument, 4300, “émission” (deed in French)
  • Board rule, “confirmation du mandat à l'organe d'administration, articles 41 à 47 de la loi du 26-03-1999” (deed in French)
  • Other provision, “attribution immédiate de droits de souscription, à la suite de la présente assemblée” (deed in French)
  • Declaration, “chaque actionnaire, droits de souscription émis dans le cadre du plan d'options sur actions” (deed in French)
  • Capital increase, “€nombre de droits de souscription exercés multiplié par leur prix d'exercice” (deed in French)
  • Other provision, “inscription desdits droits de souscription au nom des bénéficiaires, ouverture d'un registre de droits de souscription” (deed in French)
  • Power of attorney (2 times)
  • Director appointment, Séverine de Sadeleer (director)
  • +2 further facts in this act
31-07
NBB filing Annual accounts filed
financial year 2023 · full format
20-03
Gazette deed Resignation: Olivier DECUYPERE (director)
Appointment: Merlot Management (director) · Permanent representative: Olivier DECUYPERE · Power of attorney29 facts ▸
  • Power of attorney (5 times)
  • Other provision, “unanimité des voix, rapports en cas d’assimilation des droits attachés à une classe d’actions et ceux attachés à une autre classe” (deed in French)
  • Auditor report, “évaluer si les données financières et comptables figurant dans le rapport de l’organe d’administration sont fidèles et suffisantes dans tous leurs aspects signi…” (deed in French)
  • Other provision, “renonciation au droit de préférence, pour autant que de besoin” (deed in French)
  • Other provision, “dédoublement des actions A2, conversion en actions A1 et unification automatique de la classe d’actions A”, EUR (deed in French)
  • Amendment of the articles
  • Capital (2 times)
  • Director resignation, Olivier DECUYPERE (director)
  • Director appointment, Merlot Management (director)
  • Permanent representative, Olivier DECUYPERE
  • Other provision, 6 years (2 times)
  • General meeting, 08-03-2024
  • +17 further facts in this act
07-02
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 21-12-2023
  • Registered-office move, Chemin du Cyclotron 6 à 1348 Louvain-la-Neuve
2023
29-06
NBB filing Annual accounts filed
financial year 2022 · full format
2022
31-12
Financial Back to profitnet €167,922
Net result €167,922 after 2 loss-making years.
09-08
NBB filing Annual accounts filed
financial year 2021 · full format · 9 days late
Show earlier events
2021
31-12
Financial Liquidity more than 35 timescurrent ratio 2.85
Current ratio from 0.08 to 2.85.
31-12
Financial Equity above €200,000equity €324,572
Equity rises from -€143,078 to €324,572.
05-10
NBB filing Annual accounts filed
financial year 2020 · full format · 66 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
4 of 6 deeds read
About the unread acts

Of the 6 Belgian Official Gazette deeds we know for this company, 4 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure